Sovereign s Capital Management LLC Takes Position in Option Care Health, Inc. (NASDAQ:OPCH)

Sovereign s Capital Management LLC bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 73,516 shares of the company's stock, valued at approximately $1,706,000.

A number of other hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Option Care Health by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock worth $448,118,000 after acquiring an additional 75,313 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after acquiring an additional 8,400,208 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after acquiring an additional 591,042 shares during the last quarter. Northern Trust Corp raised its position in shares of Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock worth $60,934,000 after acquiring an additional 278,158 shares during the last quarter. Finally, Norges Bank bought a new position in shares of Option Care Health during the fourth quarter worth about $60,219,000. 98.05% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.64% of the company's stock.

Option Care Health Stock Down 1.9%

Option Care Health stock traded down $0.62 during mid-day trading on Friday, reaching $31.41. The stock had a trading volume of 836,498 shares, compared to its average volume of 1,858,964. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The stock's 50-day simple moving average is $32.99 and its 200-day simple moving average is $29.30. The firm has a market capitalization of $5.14 billion, a PE ratio of 26.39, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same quarter last year, the firm posted $0.26 earnings per share. The company's revenue for the quarter was up 16.3% compared to the same quarter last year. On average, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. raised their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.